|
|
|
Clinical Research Detail |
|
|
|
Title Of Study |
A Clinical Trial to demonstrate clinical superiority of Retapamulin ointment, 1%, over placebo in patients with secondarily-infected traumatic lesions, which includes secondarily-infected lacerations, abrasions and sutured wounds
|
|
|
Disease Condition |
Secondarily-Infected Traumatic Lesions Including Secondarily-Infected Lacerations Sutured Wounds and Abrasions
|
|
|
Phase of Trial |
Phase-3
|
Discipline |
General surgery
|
|
|
Start date of Trial |
5/21/2008
|
Closing Date of Trial |
5/21/2010
|
|
|
|